OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is a publicly traded Healthcare sector company. As of September 21, 2026, OKUR trades at $2.98 with a market cap of $119.46M and a P/E ratio of -0.67. OKUR moved +1.19% today. Year to date, OKUR is +1.72%; over the trailing twelve months it is +18.95%. Its 52-week range spans $1.70 to $6.48. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces OKUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover OKUR: 0 strong buy, 3 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $17.00.
| Metric | Value |
|---|---|
| Price | $2.98 |
| Market Cap | $119.46M |
| P/E Ratio | -0.67 |
| EPS | $-4.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.48 |
| 52-Week Low | $1.70 |
| Volume | 79.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.43M |
| Net Income | $-59.52M |
| Gross Margin | 0.00% |
4 analysts cover OKUR: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.